Canavan disease is a neurological disorder in infants due to a defective gene and results in death by age four,so I've read. Genetic testing is crucial in its treatment to prolong life, yet this gene is patented and requires a royalty beyond what most parents can afford to progress with the testing. The royalties supercede the importance of the treatment,so it seems.
No comments:
Post a Comment